<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<ns2:regimens xmlns:ns2="http://www.msh.org/quantb/model/regimen">
    <ns2:regimen>
        <name>2(RHZE)/4(RH) - (weight 40-54kg)</name>
        <type>Multi_Drug</type>
        <intensive>
            <order>1</order>
            <duration>2</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>4-FDC RHZE (150/75/400/275)</name>
                    <abbrevName>RHZE(150/75/400/275)</abbrevName>
                    <strength>150mg+75mg+400mg+275mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>2</duration>
                <dosage>4</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>4</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>2-FDC RH (150/75)</name>
                    <abbrevName>RH(150/75)</abbrevName>
                    <strength>150mg+75mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>4</duration>
                <dosage>4</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </continious>
        <formulation>2RHZE(150/75/400/275)/4RH(150/75)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>TestCasesQuantityRegimen</name>
        <type>Multi_Drug</type>
        <intensive>
            <order>1</order>
            <duration>3</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Amikacin</name>
                    <abbrevName>Am(500)</abbrevName>
                    <strength>500mg</strength>
                    <form>POWDER_FOR_INJECTION</form>
                    <dosage></dosage>
                    <type>Second_Line_Parenteral_Agent</type>
                </medicine>
                <duration>3</duration>
                <dosage>2</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>2</duration>
            <measure>WEEKLY</measure>
            <medications>
                <medicine>
                    <name>Amikacin</name>
                    <abbrevName>Am(500/2)</abbrevName>
                    <strength>500mg/2ml</strength>
                    <form>SOLUTION_FOR_INJECTION</form>
                    <dosage></dosage>
                    <type>Second_Line_Parenteral_Agent</type>
                </medicine>
                <duration>2</duration>
                <dosage>1</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </continious>
        <addPhases>
            <order>3</order>
            <duration>6</duration>
            <measure>WEEKLY</measure>
            <medications>
                <medicine>
                    <name>Capreomycin</name>
                    <abbrevName>Cm(1000)</abbrevName>
                    <strength>1000mg</strength>
                    <form>POWDER_FOR_INJECTION</form>
                    <dosage></dosage>
                    <type>Second_Line_Parenteral_Agent</type>
                </medicine>
                <duration>6</duration>
                <dosage>1</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </addPhases>
        <addPhases>
            <order>4</order>
            <duration>1</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Imipenem + Cilastatin</name>
                    <abbrevName>Imi/Cls(500/500)</abbrevName>
                    <strength>500mg+500mg</strength>
                    <form>POWDER_FOR_INJECTION</form>
                    <dosage></dosage>
                    <type>Group_5</type>
                </medicine>
                <duration>1</duration>
                <dosage>1</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </addPhases>
        <formulation>3Am(500)/1Am(500/2)/2Cm(1000)/1Imi/Cls(500/500)
        </formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>2(RH)ZE/4(RH) - (weight 40-54kg)</name>
        <type>Multi_Drug</type>
        <intensive>
            <order>1</order>
            <duration>2</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Pyrazinamide</name>
                    <abbrevName>Z(400)</abbrevName>
                    <strength>400mg</strength>
                    <form>FILM_UNCOATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>2</duration>
                <dosage>4</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Ethambutol</name>
                    <abbrevName>E(400)</abbrevName>
                    <strength>400mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>2</duration>
                <dosage>2</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>2-FDC RH (150/75)</name>
                    <abbrevName>RH(150/75)</abbrevName>
                    <strength>150mg+75mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>2</duration>
                <dosage>3</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>4</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>2-FDC RH (150/75)</name>
                    <abbrevName>RH(150/75)</abbrevName>
                    <strength>150mg+75mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>4</duration>
                <dosage>3</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </continious>
        <formulation>2E(400)RH(150/75)Z(400)/4RH(150/75)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>MDR-TB Regimen 1 (weight 51-70kg)</name>
        <type>Multi_Drug</type>
        <intensive>
            <order>1</order>
            <duration>8</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Capreomycin</name>
                    <abbrevName>Cm(1000)</abbrevName>
                    <strength>1000mg</strength>
                    <form>POWDER_FOR_INJECTION</form>
                    <dosage></dosage>
                    <type>Second_Line_Parenteral_Agent</type>
                </medicine>
                <duration>8</duration>
                <dosage>1</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Cycloserine</name>
                    <abbrevName>Cs(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>CAPSULE</form>
                    <dosage></dosage>
                </medicine>
                <duration>8</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Levofloxacin</name>
                    <abbrevName>Lfx(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>Fluoroquinolones</type>
                </medicine>
                <duration>8</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Protionamide </name>
                    <abbrevName>Pto(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                </medicine>
                <duration>8</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Pyrazinamide</name>
                    <abbrevName>Z(500)</abbrevName>
                    <strength>500mg</strength>
                    <form>FILM_UNCOATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>8</duration>
                <dosage>4</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>14</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Cycloserine</name>
                    <abbrevName>Cs(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>CAPSULE</form>
                    <dosage></dosage>
                </medicine>
                <duration>14</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Levofloxacin</name>
                    <abbrevName>Lfx(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>Fluoroquinolones</type>
                </medicine>
                <duration>14</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Protionamide </name>
                    <abbrevName>Pto(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                </medicine>
                <duration>14</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Pyrazinamide</name>
                    <abbrevName>Z(500)</abbrevName>
                    <strength>500mg</strength>
                    <form>FILM_UNCOATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>14</duration>
                <dosage>4</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </continious>
        <formulation>8Cm(1000)Cs(250)Lfx(250)Pto(250)Z(500)/14Cs(250)Lfx(250)Pto(250)Z(500)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>MDR-TB Regimen 2 (weight 51-70kg)</name>
        <type>Multi_Drug</type>
        <intensive>
            <order>1</order>
            <duration>9</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Kanamycin</name>
                    <abbrevName>Km(1000/4)</abbrevName>
                    <strength>1000mg/4ml</strength>
                    <form>SOLUTION_FOR_INJECTION</form>
                    <dosage></dosage>
                    <type>Second_Line_Parenteral_Agent</type>
                </medicine>
                <duration>9</duration>
                <dosage>1</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Ethionamide</name>
                    <abbrevName>Eto(125)</abbrevName>
                    <strength>125mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                </medicine>
                <duration>9</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Levofloxacin</name>
                    <abbrevName>Lfx(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>Fluoroquinolones</type>
                </medicine>
                <duration>9</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>P-aminosalicylate sodium salt</name>
                    <abbrevName>PAS(Na)</abbrevName>
                    <strength>4000mg</strength>
                    <form>OTHER</form>
                    <dosage>Powder/Sachet</dosage>
                </medicine>
                <duration>9</duration>
                <dosage>2</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Pyrazinamide</name>
                    <abbrevName>Z(500)</abbrevName>
                    <strength>500mg</strength>
                    <form>FILM_UNCOATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>9</duration>
                <dosage>4</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>14</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Ethionamide</name>
                    <abbrevName>Eto(125)</abbrevName>
                    <strength>125mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                </medicine>
                <duration>14</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Levofloxacin</name>
                    <abbrevName>Lfx(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>Fluoroquinolones</type>
                </medicine>
                <duration>14</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>P-aminosalicylate sodium salt</name>
                    <abbrevName>PAS(Na)</abbrevName>
                    <strength>4000mg</strength>
                    <form>OTHER</form>
                    <dosage>Powder/Sachet</dosage>
                </medicine>
                <duration>14</duration>
                <dosage>2</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Pyrazinamide</name>
                    <abbrevName>Z(500)</abbrevName>
                    <strength>500mg</strength>
                    <form>FILM_UNCOATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>14</duration>
                <dosage>4</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </continious>
        <formulation>9Km(1000/4)Eto(125)Lfx(250)PAS(Na)Z(500)/14Eto(125)Lfx(250)PAS(Na)Z(500)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>Amikacin 8 months</name>
        <type>Single_Drug</type>
        <intensive>
            <order>1</order>
            <duration>8</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Amikacin</name>
                    <abbrevName>Am(500/2)</abbrevName>
                    <strength>500mg/2ml</strength>
                    <form>SOLUTION_FOR_INJECTION</form>
                    <dosage></dosage>
                    <type>Second_Line_Parenteral_Agent</type>
                </medicine>
                <duration>8</duration>
                <dosage>1</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>0</duration>
            <measure>MONTHLY</measure>
        </continious>
        <formulation>8Am(500/2)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>Capreomycin 8 months</name>
        <type>Single_Drug</type>
        <intensive>
            <order>1</order>
            <duration>8</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Capreomycin</name>
                    <abbrevName>Cm(1000)</abbrevName>
                    <strength>1000mg</strength>
                    <form>POWDER_FOR_INJECTION</form>
                    <dosage></dosage>
                    <type>Second_Line_Parenteral_Agent</type>
                </medicine>
                <duration>8</duration>
                <dosage>1</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>0</duration>
            <measure>MONTHLY</measure>
        </continious>
        <formulation>8Cm(1000)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>Kanamycin 8 months</name>
        <type>Single_Drug</type>
        <intensive>
            <order>1</order>
            <duration>9</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Kanamycin</name>
                    <abbrevName>Km(1000)</abbrevName>
                    <strength>1000mg</strength>
                    <form>POWDER_FOR_INJECTION</form>
                    <dosage></dosage>
                    <type>Second_Line_Parenteral_Agent</type>
                </medicine>
                <duration>9</duration>
                <dosage>1</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>0</duration>
            <measure>MONTHLY</measure>
        </continious>
        <formulation>8Km(1000)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>Cycloserine 22 months</name>
        <type>Single_Drug</type>
        <intensive>
            <order>1</order>
            <duration>22</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Cycloserine</name>
                    <abbrevName>Cs(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>CAPSULE</form>
                    <dosage></dosage>
                </medicine>
                <duration>22</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>0</duration>
            <measure>MONTHLY</measure>
        </continious>
        <formulation>22Cs(250)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>Levofloxacin 22 months</name>
        <type>Single_Drug</type>
        <intensive>
            <order>1</order>
            <duration>22</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Levofloxacin</name>
                    <abbrevName>Lfx(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>Fluoroquinolones</type>
                </medicine>
                <duration>22</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>0</duration>
            <measure>MONTHLY</measure>
        </continious>
        <formulation>22Lfx(250)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>Prothionamide 22 months</name>
        <type>Single_Drug</type>
        <intensive>
            <order>1</order>
            <duration>22</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Protionamide </name>
                    <abbrevName>Pto(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                </medicine>
                <duration>22</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>0</duration>
            <measure>MONTHLY</measure>
        </continious>
        <formulation>22Pto(250)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>Pyrazinamide 22 months</name>
        <type>Single_Drug</type>
        <intensive>
            <order>1</order>
            <duration>22</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Pyrazinamide</name>
                    <abbrevName>Z(500)</abbrevName>
                    <strength>500mg</strength>
                    <form>FILM_UNCOATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>22</duration>
                <dosage>4</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>0</duration>
            <measure>MONTHLY</measure>
        </continious>
        <formulation>22Z(500)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>Ethionamide 22 months</name>
        <type>Single_Drug</type>
        <intensive>
            <order>1</order>
            <duration>22</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Ethionamide</name>
                    <abbrevName>Eto(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                </medicine>
                <duration>22</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>0</duration>
            <measure>MONTHLY</measure>
        </continious>
        <formulation>22Eto(250)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>P-aminosalicylate sodium salt 22 months</name>
        <type>Single_Drug</type>
        <intensive>
            <order>1</order>
            <duration>22</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>P-aminosalicylate sodium salt</name>
                    <abbrevName>PAS(Na)</abbrevName>
                    <strength>4000mg</strength>
                    <form>OTHER</form>
                    <dosage>Powder/Sachet</dosage>
                </medicine>
                <duration>22</duration>
                <dosage>2</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>0</duration>
            <measure>MONTHLY</measure>
        </continious>
        <formulation>22PAS(Na)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>Longer MDR-TB Regimen 1: (weight 56-70kg)</name>
        <type>Multi_Drug</type>
        <intensive>
            <order>1</order>
            <duration>7</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Capreomycin</name>
                    <abbrevName>Cm(1000)</abbrevName>
                    <strength>1000mg</strength>
                    <form>POWDER_FOR_INJECTION</form>
                    <dosage></dosage>
                    <type>Second_Line_Parenteral_Agent</type>
                </medicine>
                <duration>7</duration>
                <dosage>1</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Cycloserine</name>
                    <abbrevName>Cs(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>CAPSULE</form>
                    <dosage></dosage>
                </medicine>
                <duration>7</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Levofloxacin</name>
                    <abbrevName>Lfx(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>Fluoroquinolones</type>
                </medicine>
                <duration>7</duration>
                <dosage>4</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Protionamide </name>
                    <abbrevName>Pto(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                </medicine>
                <duration>7</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Pyrazinamide</name>
                    <abbrevName>Z(500)</abbrevName>
                    <strength>500mg</strength>
                    <form>FILM_UNCOATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>7</duration>
                <dosage>4</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Syringe &amp; needle (auto-disabling)</name>
                    <abbrevName>S&amp;N-5/21Gx1.5 and Safety Box </abbrevName>
                    <strength>21G</strength>
                    <form>NA</form>
                    <dosage>Syringe &amp; needle </dosage>
                    <type>Other</type>
                    <classifier>OTHER_SUPPLIERS_MEDICINES</classifier>
                </medicine>
                <duration>7</duration>
                <dosage>2</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Water for injection</name>
                    <abbrevName>WFI(5)</abbrevName>
                    <strength>5ml</strength>
                    <form>NA</form>
                    <dosage>Water</dosage>
                    <type>Other</type>
                    <classifier>OTHER_SUPPLIERS_MEDICINES</classifier>
                </medicine>
                <duration>7</duration>
                <dosage>1</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>14</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Cycloserine</name>
                    <abbrevName>Cs(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>CAPSULE</form>
                    <dosage></dosage>
                </medicine>
                <duration>14</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Levofloxacin</name>
                    <abbrevName>Lfx(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>Fluoroquinolones</type>
                </medicine>
                <duration>14</duration>
                <dosage>4</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Protionamide </name>
                    <abbrevName>Pto(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                </medicine>
                <duration>14</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Pyrazinamide</name>
                    <abbrevName>Z(500)</abbrevName>
                    <strength>500mg</strength>
                    <form>FILM_UNCOATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>14</duration>
                <dosage>4</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Syringe &amp; needle (auto-disabling)</name>
                    <abbrevName>S&amp;N-5/21Gx1.5 and Safety Box </abbrevName>
                    <strength>21G</strength>
                    <form>NA</form>
                    <dosage>Syringe &amp; needle </dosage>
                    <type>Other</type>
                    <classifier>OTHER_SUPPLIERS_MEDICINES</classifier>
                </medicine>
                <duration>14</duration>
                <dosage>2</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Water for injection</name>
                    <abbrevName>WFI(5)</abbrevName>
                    <strength>5ml</strength>
                    <form>NA</form>
                    <dosage>Water</dosage>
                    <type>Other</type>
                    <classifier>OTHER_SUPPLIERS_MEDICINES</classifier>
                </medicine>
                <duration>14</duration>
                <dosage>1</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </continious>
        <formulation>7Cm(1000)Cs(250)Lfx(250)Pto(250)S&amp;N-5/21Gx1.5 and Safety Box WFI(5)Z(500)/14Cs(250)Lfx(250)Pto(250)S&amp;N-5/21Gx1.5 and Safety Box WFI(5)Z(500)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>Longer MDR-TB Regimen 2: (weight 56-70kg)</name>
        <type>Multi_Drug</type>
        <intensive>
            <order>1</order>
            <duration>8</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Kanamycin</name>
                    <abbrevName>Km(1000/4)</abbrevName>
                    <strength>1000mg/4ml</strength>
                    <form>SOLUTION_FOR_INJECTION</form>
                    <dosage></dosage>
                    <type>Second_Line_Parenteral_Agent</type>
                </medicine>
                <duration>8</duration>
                <dosage>1</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Levofloxacin</name>
                    <abbrevName>Lfx(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>Fluoroquinolones</type>
                </medicine>
                <duration>8</duration>
                <dosage>4</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>P-aminosalicylate sodium salt</name>
                    <abbrevName>PAS(Na)</abbrevName>
                    <strength>4000mg</strength>
                    <form>OTHER</form>
                    <dosage>Powder/Sachet</dosage>
                </medicine>
                <duration>8</duration>
                <dosage>2</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Pyrazinamide</name>
                    <abbrevName>Z(500)</abbrevName>
                    <strength>500mg</strength>
                    <form>FILM_UNCOATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>8</duration>
                <dosage>4</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Ethionamide</name>
                    <abbrevName>Eto(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>Second_Line_Oral_Bacteriostatic</type>
                    <classifier>OTHER_CORE_SECOND_LINE</classifier>
                </medicine>
                <duration>8</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Syringe &amp; needle (auto-disabling)</name>
                    <abbrevName>S&amp;N-5/21Gx1.5 and Safety Box </abbrevName>
                    <strength>21G</strength>
                    <form>NA</form>
                    <dosage>Syringe &amp; needle </dosage>
                    <type>Other</type>
                    <classifier>OTHER_SUPPLIERS_MEDICINES</classifier>
                </medicine>
                <duration>8</duration>
                <dosage>2</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Water for injection</name>
                    <abbrevName>WFI(5)</abbrevName>
                    <strength>5ml</strength>
                    <form>NA</form>
                    <dosage>Water</dosage>
                    <type>Other</type>
                    <classifier>OTHER_SUPPLIERS_MEDICINES</classifier>
                </medicine>
                <duration>8</duration>
                <dosage>1</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>14</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Levofloxacin</name>
                    <abbrevName>Lfx(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>Fluoroquinolones</type>
                </medicine>
                <duration>14</duration>
                <dosage>4</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>P-aminosalicylate sodium salt</name>
                    <abbrevName>PAS(Na)</abbrevName>
                    <strength>4000mg</strength>
                    <form>OTHER</form>
                    <dosage>Powder/Sachet</dosage>
                </medicine>
                <duration>14</duration>
                <dosage>2</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Pyrazinamide</name>
                    <abbrevName>Z(500)</abbrevName>
                    <strength>500mg</strength>
                    <form>FILM_UNCOATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                </medicine>
                <duration>14</duration>
                <dosage>4</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Ethionamide</name>
                    <abbrevName>Eto(250)</abbrevName>
                    <strength>250mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>Second_Line_Oral_Bacteriostatic</type>
                    <classifier>OTHER_CORE_SECOND_LINE</classifier>
                </medicine>
                <duration>14</duration>
                <dosage>3</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Syringe &amp; needle (auto-disabling)</name>
                    <abbrevName>S&amp;N-5/21Gx1.5 and Safety Box </abbrevName>
                    <strength>21G</strength>
                    <form>NA</form>
                    <dosage>Syringe &amp; needle </dosage>
                    <type>Other</type>
                    <classifier>OTHER_SUPPLIERS_MEDICINES</classifier>
                </medicine>
                <duration>14</duration>
                <dosage>2</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Water for injection</name>
                    <abbrevName>WFI(5)</abbrevName>
                    <strength>5ml</strength>
                    <form>NA</form>
                    <dosage>Water</dosage>
                    <type>Other</type>
                    <classifier>OTHER_SUPPLIERS_MEDICINES</classifier>
                </medicine>
                <duration>14</duration>
                <dosage>1</dosage>
                <daysPerWeek>6</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </continious>
        <formulation>8Km(1000/4)Eto(250)Lfx(250)PAS(Na)S&amp;N-5/21Gx1.5 and Safety Box WFI(5)Z(500)/14Eto(250)Lfx(250)PAS(Na)S&amp;N-5/21Gx1.5 and Safety Box WFI(5)Z(500)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>2(RH)ZE/4(RH) - (weight 40-54kg) - Copy</name>
        <type>Multi_Drug</type>
        <intensive>
            <order>1</order>
            <duration>3</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Pyrazinamide</name>
                    <abbrevName>Z(400)</abbrevName>
                    <strength>400mg</strength>
                    <form>FILM_UNCOATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                    <classifier>UNKNOWN</classifier>
                </medicine>
                <duration>3</duration>
                <dosage>2</dosage>
                <daysPerWeek>3</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Ethambutol</name>
                    <abbrevName>E(400)</abbrevName>
                    <strength>400mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                    <classifier>UNKNOWN</classifier>
                </medicine>
                <duration>3</duration>
                <dosage>2</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>2-FDC RH (150/75)</name>
                    <abbrevName>RH(150/75)</abbrevName>
                    <strength>150mg+75mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                    <classifier>UNKNOWN</classifier>
                </medicine>
                <duration>3</duration>
                <dosage>3</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>4</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>2-FDC RH (150/75)</name>
                    <abbrevName>RH(150/75)</abbrevName>
                    <strength>150mg+75mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                    <classifier>UNKNOWN</classifier>
                </medicine>
                <duration>4</duration>
                <dosage>3</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </continious>
        <formulation>3E(400)RH(150/75)Z(400)/4RH(150/75)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>test</name>
        <type>Multi_Drug</type>
        <intensive>
            <order>1</order>
            <duration>1</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Amikacin</name>
                    <abbrevName>Am(500)</abbrevName>
                    <strength>500mg</strength>
                    <form>POWDER_FOR_INJECTION</form>
                    <dosage></dosage>
                    <type>Second_Line_Parenteral_Agent</type>
                    <classifier>SECOND_LINE_INJECT</classifier>
                </medicine>
                <duration>1</duration>
                <dosage>1</dosage>
                <daysPerWeek>1</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Amikacin</name>
                    <abbrevName>Am(500/2)</abbrevName>
                    <strength>500mg/2ml</strength>
                    <form>SOLUTION_FOR_INJECTION</form>
                    <dosage></dosage>
                    <type>Second_Line_Parenteral_Agent</type>
                    <classifier>SECOND_LINE_INJECT</classifier>
                </medicine>
                <duration>1</duration>
                <dosage>1</dosage>
                <daysPerWeek>1</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>0</duration>
            <measure>MONTHLY</measure>
        </continious>
        <formulation></formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:regimen>
        <name>2(RH)ZE/4(RH) - (weight 40-54kg) - Copy</name>
        <type>Multi_Drug</type>
        <intensive>
            <order>1</order>
            <duration>2</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>Pyrazinamide</name>
                    <abbrevName>Z(400)</abbrevName>
                    <strength>400mg</strength>
                    <form>FILM_UNCOATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                    <classifier>UNKNOWN</classifier>
                </medicine>
                <duration>2</duration>
                <dosage>4</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>Ethambutol</name>
                    <abbrevName>E(400)</abbrevName>
                    <strength>400mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                    <classifier>UNKNOWN</classifier>
                </medicine>
                <duration>2</duration>
                <dosage>2</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
            <medications>
                <medicine>
                    <name>2-FDC RH (150/75)</name>
                    <abbrevName>RH(150/75)</abbrevName>
                    <strength>150mg+75mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                    <classifier>UNKNOWN</classifier>
                </medicine>
                <duration>2</duration>
                <dosage>3</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </intensive>
        <continious>
            <order>2</order>
            <duration>4</duration>
            <measure>MONTHLY</measure>
            <medications>
                <medicine>
                    <name>2-FDC RH (150/75)</name>
                    <abbrevName>RH(150/75)</abbrevName>
                    <strength>150mg+75mg</strength>
                    <form>FILM_COATED_TABLET</form>
                    <dosage></dosage>
                    <type>First_Line</type>
                    <classifier>UNKNOWN</classifier>
                </medicine>
                <duration>4</duration>
                <dosage>3</dosage>
                <daysPerWeek>7</daysPerWeek>
                <startWeek>0</startWeek>
                <endWeek>0</endWeek>
            </medications>
        </continious>
        <formulation>2E(400)RH(150/75)Z(400)/4RH(150/75)</formulation>
        <duration>0</duration>
    </ns2:regimen>
    <ns2:stamp name="USER">
        <lastUpdated>2017-05-22T17:08:47.406+03:00</lastUpdated>
    </ns2:stamp>
</ns2:regimens>
